Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study
暂无分享,去创建一个
O. Casasnovas | P. Feugier | C. Haioun | M. Meignan | G. Paintaud | F. Morschhauser | E. Gyan | G. Cartron | D. Ternant | Mira Tout | Sami Boussetta | Gilles Salles | Thierry Lamy | Mélanie Mercier